PT72878B
(en)
|
1980-04-24 |
1983-03-29 |
Merck & Co Inc |
Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
TW544448B
(en)
|
1997-07-11 |
2003-08-01 |
Novartis Ag |
Pyridine derivatives
|
GB9802251D0
(en)
|
1998-02-03 |
1998-04-01 |
Ciba Geigy Ag |
Organic compounds
|
ATE255894T1
(de)
|
1998-10-02 |
2003-12-15 |
Novartis Pharma Gmbh |
Mglur5 antagonisten zur behandlung von schmerzen und angstzuständen
|
US6525203B1
(en)
|
1999-03-12 |
2003-02-25 |
Bristol-Myers Squibb Company |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
CA2409006A1
(en)
*
|
2000-05-31 |
2001-12-06 |
Warner-Lambert Company |
Biciclic cyclohexylamines and their use as nmda receptor antogonists
|
GB0028702D0
(en)
|
2000-11-24 |
2001-01-10 |
Novartis Ag |
Organic compounds
|
JP4205430B2
(ja)
|
2001-03-26 |
2009-01-07 |
ノバルティス アクチエンゲゼルシャフト |
疼痛を治療するための、バニロイド受容体アンタゴニストとして、使用するための縮合ピリジン誘導体
|
EP2944648B1
(en)
|
2001-03-29 |
2019-11-13 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists for the treatment of organ inflammation
|
JP3894035B2
(ja)
|
2001-07-04 |
2007-03-14 |
東レ株式会社 |
炭素繊維強化基材、それからなるプリフォームおよび複合材料
|
TW200306839A
(en)
|
2002-02-06 |
2003-12-01 |
Novartis Ag |
Quinazolinone derivatives and their use as CB agonists
|
US6696468B2
(en)
|
2002-05-16 |
2004-02-24 |
Dainippon Pharmaceutical Co., Ltd. |
(s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
|
SE0201940D0
(sv)
|
2002-06-20 |
2002-06-20 |
Astrazeneca Ab |
New combination II
|
DOP2003000703A
(es)
|
2002-09-20 |
2004-03-31 |
Pfizer |
Compuestos de imidazopiradina como agonistas del receptor 5-ht4
|
GB0223730D0
(en)
|
2002-10-11 |
2002-11-20 |
Novartis Ag |
Organic compounds
|
PE20040844A1
(es)
|
2002-11-26 |
2004-12-30 |
Novartis Ag |
Acidos fenilaceticos y derivados como inhibidores de la cox-2
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
GB0302876D0
(en)
|
2003-02-07 |
2003-03-12 |
Novartis Ag |
Organic compounds
|
JP2007524596A
(ja)
|
2003-02-28 |
2007-08-30 |
トランスフォーム・ファーマシューティカルズ・インコーポレイテッド |
共結晶医薬組成物
|
JP2004277319A
(ja)
|
2003-03-14 |
2004-10-07 |
Dainippon Pharmaceut Co Ltd |
1−(4−ピペリジニルメチル)ピペリジニルアミド誘導体およびそれを含有する医薬組成物
|
JP2004277318A
(ja)
|
2003-03-14 |
2004-10-07 |
Dainippon Pharmaceut Co Ltd |
1−(1−置換カルボニル−4−ピペリジニルメチル)ピペリジン誘導体およびそれを含有する医薬組成物
|
DK1644021T3
(da)
|
2003-06-13 |
2012-10-29 |
Ironwood Pharmaceuticals Inc |
Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
|
US7491695B2
(en)
|
2003-06-18 |
2009-02-17 |
Tranzyme Pharma Inc. |
Methods of using macrocyclic modulators of the ghrelin receptor
|
US7476653B2
(en)
|
2003-06-18 |
2009-01-13 |
Tranzyme Pharma, Inc. |
Macrocyclic modulators of the ghrelin receptor
|
EP1505064A1
(en)
|
2003-08-05 |
2005-02-09 |
Bayer HealthCare AG |
2-Aminopyrimidine derivatives
|
EP1656145A1
(en)
|
2003-08-12 |
2006-05-17 |
F. Hoffmann-La Roche Ag |
Spiro-substituted tetrahydroquinazolines as corticotropin releasing factor (cfr) antagonists
|
ATE374190T1
(de)
|
2003-08-12 |
2007-10-15 |
Hoffmann La Roche |
Tetrahydrochinazolinderivate als cfr-antagonisten
|
EP1664010A1
(en)
|
2003-08-29 |
2006-06-07 |
Vernalis (R&D) Limited |
Sulfonamides antagonising n-type calcium channels
|
JP2007504243A
(ja)
|
2003-09-03 |
2007-03-01 |
ニューロジェン・コーポレーション |
5−アリール−ピラゾロ[4,3−d]ピリミジン類、ピリジン類、ピラジン類及び関連化合物
|
BRPI0414105B8
(pt)
|
2003-09-03 |
2021-05-25 |
Askat Inc |
compostos de benzimidazolona com atividade agonista do receptor 5-ht4
|
EP1680424A2
(en)
|
2003-09-05 |
2006-07-19 |
Neurogen Corporation |
Heteroaryl fused pyridines, pyrazines and pyrimidines as crf1 receptor ligands
|
JP2005082508A
(ja)
|
2003-09-05 |
2005-03-31 |
Dainippon Pharmaceut Co Ltd |
2−アルコキシ−6−アミノ−5−ハロゲノ−n−(1−置換−4−ピペリジニル)ピリジン−3−カルボキサミド誘導体およびそれを含有する医薬組成物
|
EP1666468A4
(en)
|
2003-09-09 |
2007-03-21 |
Ono Pharmaceutical Co |
CRF ANTAGONISTS AND HETEROBICYCLIC COMPOUNDS
|
GB0322612D0
(en)
|
2003-09-26 |
2003-10-29 |
Novartis Ag |
Organic compounds
|
US7432378B2
(en)
|
2003-09-30 |
2008-10-07 |
Janssen Pharmaceutica, N.V. |
Benzoimidazole compounds
|
JP2005104896A
(ja)
|
2003-09-30 |
2005-04-21 |
Dainippon Pharmaceut Co Ltd |
2−アルコキシ−6−アミノ−5−ハロゲノピリジン−3−カルボキサミド誘導体およびそれを含有する医薬組成物
|
JP2007507514A
(ja)
|
2003-09-30 |
2007-03-29 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
キノキサリン化合物
|
WO2005044266A1
(en)
|
2003-10-31 |
2005-05-19 |
Astrazeneca Ab |
Alkynes i
|
EP1677791A4
(en)
|
2003-10-31 |
2007-08-15 |
Takeda Pharmaceutical |
NITROGENIC CONDENSED HETEROCYCLIC COMPOUNDS
|
CN1922156A
(zh)
|
2003-11-10 |
2007-02-28 |
默克公司 |
作为钠通道阻断剂的取代的***
|
US7208596B2
(en)
|
2003-11-25 |
2007-04-24 |
Bristol-Myers Squibb Pharma Company |
Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
|
WO2005054239A1
(en)
|
2003-12-05 |
2005-06-16 |
Bayer Healthcare Ag |
2-aminopyrimidine derivatives
|
US7211568B2
(en)
|
2003-12-18 |
2007-05-01 |
Kosan Biosciences Incorporated |
9-Desoxoerythromycin compounds as prokinetic agents
|
EP1713791B1
(en)
|
2003-12-19 |
2008-04-30 |
AstraZeneca AB |
5-fluoro- and chloro-pyridin-2-yl-tetrazoles as ligands of the metabotropic glutamate receptor-5
|
JP2005206590A
(ja)
|
2003-12-25 |
2005-08-04 |
Mitsubishi Pharma Corp |
ナトリウムチャネルサイト2選択的阻害剤
|
EP2194053B1
(en)
|
2004-01-07 |
2013-03-27 |
Armetheon, Inc. |
Methoxy piperidine derivatives for use inr the treatment of gastrointestinal and central nervous system disorders
|
TW200530181A
(en)
|
2004-01-13 |
2005-09-16 |
Bristol Myers Squibb Co |
Heterocyclic compounds useful as growth hormone secretagogues
|
ATE388146T1
(de)
|
2004-01-29 |
2008-03-15 |
Pfizer |
1-isopropyl-2-oxo-1,2-dihydropyridin-3- carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor
|
WO2005077373A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
WO2005077345A1
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Compounds for the treatment of gastro-esophageal reflux disease
|
TW200533348A
(en)
|
2004-02-18 |
2005-10-16 |
Theravance Inc |
Indazole-carboxamide compounds as 5-ht4 receptor agonists
|
KR20070026382A
(ko)
|
2004-02-18 |
2007-03-08 |
아스트라제네카 아베 |
아세틸린성 피페라진 화합물 및 대사성 글루타메이트수용체 길항제로서 이들의 용도
|
US7585881B2
(en)
|
2004-02-18 |
2009-09-08 |
Astrazeneca Ab |
Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
AU2005214379B2
(en)
|
2004-02-18 |
2012-03-22 |
Astrazeneca Ab |
Tetrazole compounds and their use as metabotropic glutamate receptor antagonits
|
BRPI0507501A
(pt)
|
2004-02-18 |
2007-06-26 |
Astrazeneca Ab |
composto, composição farmacêutica, uso do composto, método para o tratamento de distúrbios mediados por mglur5, e, método para inibir a ativação de receptores de mglur5
|
AU2005214378A1
(en)
|
2004-02-18 |
2005-09-01 |
Astrazeneca Ab |
Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists
|
MY152888A
(en)
|
2004-02-18 |
2014-11-28 |
Astrazeneca Ab |
Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists.
|
AU2005214380A1
(en)
|
2004-02-18 |
2005-09-01 |
Astrazeneca Ab |
Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders
|
TW200538180A
(en)
|
2004-02-20 |
2005-12-01 |
Astrazeneca Ab |
New compounds
|
WO2005092882A1
(en)
|
2004-03-01 |
2005-10-06 |
Pfizer Japan, Inc. |
4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders
|
US7087749B2
(en)
|
2004-03-11 |
2006-08-08 |
Adolor Corporation |
Substituted piperidine compounds and methods of their use
|
KR101217103B1
(ko)
|
2004-03-25 |
2012-12-31 |
얀센 파마슈티카 엔.브이. |
이미다졸 화합물
|
WO2005097136A1
(en)
|
2004-03-29 |
2005-10-20 |
Merck & Co., Inc. |
Biaryl substituted pyrazinones as sodium channel blockers
|
CA2561801A1
(en)
|
2004-04-02 |
2005-10-20 |
Elixir Pharmaceuticals, Inc. |
Sulfonamides and uses thereof
|
TWI351282B
(en)
|
2004-04-07 |
2011-11-01 |
Theravance Inc |
Quinolinone-carboxamide compounds as 5-ht4 recepto
|
WO2005115399A2
(en)
|
2004-04-16 |
2005-12-08 |
Neurogen Corporation |
Imidazopyrazines, imidazopyridines, ans imidazopyrimidines as crf1 receptor ligands
|
GB0412768D0
(en)
|
2004-06-08 |
2004-07-07 |
Novartis Ag |
Organic compounds
|
GB0412769D0
(en)
|
2004-06-08 |
2004-07-07 |
Novartis Ag |
Organic compounds
|
EP1758891A2
(en)
|
2004-06-15 |
2007-03-07 |
Pfizer Japan Inc. |
Benzimidazolone carboxylic acid derivatives
|
AR049300A1
(es)
|
2004-06-15 |
2006-07-12 |
Schering Corp |
Compuestos triciclicos antagonistas de mglur1 como agentes terapeuticos
|
SE0401653D0
(sv)
|
2004-06-24 |
2004-06-24 |
Astrazeneca Ab |
New compounds
|
WO2006006740A1
(ja)
|
2004-07-14 |
2006-01-19 |
Japan Tobacco Inc. |
3−アミノベンズアミド化合物及びバニロイド受容体1型(vr1)活性阻害剤
|
CA2571133C
(en)
|
2004-07-15 |
2011-04-19 |
Japan Tobacco Inc. |
Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor
|
EP1768669B1
(en)
|
2004-07-19 |
2009-11-11 |
Institut de Recherche pour le Développement ( IRD) |
Pharmaceutical compositions for the treatment of leishmaniasis
|
US7381728B2
(en)
|
2004-07-28 |
2008-06-03 |
Glaxo Group Limited |
Piperazine derivatives useful for the treatment of gastrointestinal disorders
|
ITMI20041566A1
(it)
|
2004-07-30 |
2004-10-30 |
Indena Spa |
"trpv1 agonisti, formulazioni che li contengono e loro usi"
|
WO2006016218A1
(en)
|
2004-08-03 |
2006-02-16 |
Pfizer Japan Inc. |
Aryl or heteroaryl carbonyl derivatives derivatives useful as vanilloid receptor 1 (vr1) antagonists
|
WO2006023757A2
(en)
|
2004-08-19 |
2006-03-02 |
University Of Virginia Patent Foundation |
Novel tricyclic, bicyclic, monocyclic, and acyclic amines as potent sodium channel blocking agents
|
CA2579143A1
(en)
|
2004-09-13 |
2006-03-23 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
GB0420424D0
(en)
|
2004-09-14 |
2004-10-20 |
Ionix Pharmaceuticals Ltd |
Therapeutic compounds
|
US20060063792A1
(en)
|
2004-09-17 |
2006-03-23 |
Adolor Corporation |
Substituted morphinans and methods of their use
|
SE0402284D0
(sv)
|
2004-09-21 |
2004-09-21 |
Astrazeneca Ab |
New heterocyclic amides
|
EP1797090A4
(en)
|
2004-09-27 |
2009-11-11 |
Elixir Pharmaceuticals Inc |
SULFONAMIDES AND USES THEREOF
|
WO2006038594A1
(ja)
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
N型カルシウムチャネル阻害薬
|
JP5635727B2
(ja)
|
2004-10-07 |
2014-12-03 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
チアゾリルmglur5アンタゴニスト及びそれらの使用のための方法
|
US20080070946A1
(en)
|
2004-10-08 |
2008-03-20 |
Astrazeneca Ab |
Hydroxymethylbenzothiazoles Amides
|
US8143425B2
(en)
|
2004-10-12 |
2012-03-27 |
Bristol-Myers Squibb Company |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
US7439360B2
(en)
|
2004-10-15 |
2008-10-21 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
DE602005014375D1
(de)
|
2004-10-19 |
2009-06-18 |
Neurocrine Biosciences Inc |
Crf-rezeptor-antagonisten und zugehörige verfahren
|
GB0519957D0
(en)
|
2005-09-30 |
2005-11-09 |
Sb Pharmco Inc |
Chemical compound
|
WO2006047492A2
(en)
|
2004-10-22 |
2006-05-04 |
Amgen Inc. |
Substituted nitrogen-containing heterocycles as vanilloid receptor ligands and their uses as medicament
|
WO2006048771A1
(en)
|
2004-11-04 |
2006-05-11 |
Addex Pharmaceuticals Sa |
Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
|
ATE431824T1
(de)
|
2004-11-05 |
2009-06-15 |
Theravance Inc |
Chinolinon-carboxamid-verbindungen
|
DE602005016446D1
(de)
|
2004-11-05 |
2009-10-15 |
Theravance Inc |
5-HT4-Rezeptoragonistenverbindungen
|
CA2586316A1
(en)
|
2004-11-11 |
2006-05-18 |
Argenta Discovery Ltd. |
Pyrimidine compounds as histamine modulators
|
US20060111416A1
(en)
|
2004-11-24 |
2006-05-25 |
Lane Charlotte A L |
Octahydropyrrolo[3,4-C]pyrrole derivatives
|
EP2527339A1
(en)
|
2004-11-24 |
2012-11-28 |
Abbott Laboratories |
Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
|
WO2006058338A2
(en)
|
2004-11-29 |
2006-06-01 |
Janssen Pharmaceutica N.V. |
4 - piperidinecarboxamide derivatives as modulators of vanilloid vr1 receptor
|
US7875627B2
(en)
|
2004-12-07 |
2011-01-25 |
Abbott Laboratories |
Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
|
US20060128710A1
(en)
|
2004-12-09 |
2006-06-15 |
Chih-Hung Lee |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
US7615570B2
(en)
|
2004-12-13 |
2009-11-10 |
Abbott Laboratories |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
SE0403117D0
(sv)
|
2004-12-21 |
2004-12-21 |
Astrazeneca Ab |
New compounds 1
|
SE0403118D0
(sv)
|
2004-12-21 |
2004-12-21 |
Astrazeneca Ab |
New compounds 2
|
ES2347265T3
(es)
|
2004-12-22 |
2010-10-27 |
Theravance, Inc. |
Compuestos de indazol-carboxamida.
|
SE0403171D0
(sv)
|
2004-12-23 |
2004-12-23 |
Astrazeneca Ab |
New compounds
|
US20080085901A1
(en)
|
2005-01-14 |
2008-04-10 |
Neurogen Corporation |
Heteroaryl Substituted Quinolin-4-Ylamine Analogues
|
MX2007008410A
(es)
|
2005-01-14 |
2007-08-21 |
Hoffmann La Roche |
Derivados de tiazol-4-carboxamida como antagonistas de receptor de glutamato metabotropico 5-.
|
US7429608B2
(en)
|
2005-01-20 |
2008-09-30 |
Amgen Inc. |
Benzo[d]imidazol analogs as vanilloid receptor ligands and their use in treatments
|
WO2006089311A1
(en)
|
2005-02-15 |
2006-08-24 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
EP1848716A1
(en)
|
2005-02-17 |
2007-10-31 |
Theravance, Inc. |
Crystalline form of an indazole-carboxamide compound
|
GB0503646D0
(en)
|
2005-02-22 |
2005-03-30 |
Novartis Ag |
Organic compounds
|
CN101133064B
(zh)
|
2005-03-03 |
2011-02-23 |
詹森药业有限公司 |
取代的氧杂-二氮杂-螺-[5.5]-十一烷酮衍生物及其作为神经激肽拮抗剂的应用
|
CA2600409C
(en)
|
2005-03-10 |
2011-07-05 |
Pfizer Inc. |
Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
|
US20060211710A1
(en)
|
2005-03-17 |
2006-09-21 |
Pfizer Inc |
Substituted aryl 1,4-pyrazine derivatives
|
GB0506147D0
(en)
|
2005-03-24 |
2005-05-04 |
Merck Sharp & Dohme |
Therapeutic agents
|
EP1863756A1
(en)
|
2005-03-24 |
2007-12-12 |
Janssen Pharmaceutica N.V. |
Biaryl derived amide modulators of vanilloid vr1 receptor
|
US20060293309A1
(en)
|
2005-03-28 |
2006-12-28 |
Dynogen Pharmaceuticals, Inc. |
Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
|
TWI377206B
(en)
|
2005-04-06 |
2012-11-21 |
Theravance Inc |
Crystalline form of a quinolinone-carboxamide compound
|
EP1877400A1
(en)
|
2005-04-15 |
2008-01-16 |
Amgen, Inc |
Vanilloid receptor ligands and their use in treatments
|
GB0508314D0
(en)
|
2005-04-25 |
2005-06-01 |
Novartis Ag |
Organic compounds
|
GB0508319D0
(en)
|
2005-04-25 |
2005-06-01 |
Novartis Ag |
Organic compounds
|
US20060241296A1
(en)
|
2005-04-25 |
2006-10-26 |
Doherty Elizabeth M |
Vanilloid receptor ligands and their use in treatments
|
GB0508318D0
(en)
|
2005-04-25 |
2005-06-01 |
Novartis Ag |
Organic compounds
|
GB0509573D0
(en)
|
2005-05-11 |
2005-06-15 |
Merck Sharp & Dohme |
Therapeutic compounds
|
JP4862042B2
(ja)
|
2005-05-11 |
2012-01-25 |
アボット・ラボラトリーズ |
バニロイド受容体サブタイプ1(vr1)のアンタゴニスト及びその使用
|
CA2607929A1
(en)
|
2005-05-11 |
2006-11-16 |
Merck Sharp & Dohme Limited |
2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1)
|
MX2007013931A
(es)
|
2005-05-12 |
2008-01-11 |
Amgen Inc |
Agentes antipireticos contra incrementos en la temperatura corporal inducidos por antagonista del receptor vainilloide 1.
|
GB0510141D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B3
|
DE102005038947A1
(de)
|
2005-05-18 |
2006-11-30 |
Grünenthal GmbH |
Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
|
GB0510142D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds A1
|
GB0510140D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B2
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
DE102005023588A1
(de)
|
2005-05-18 |
2006-11-23 |
Grünenthal GmbH |
Salze substituierter Allophansäureester und deren Verwendung in Arzneimitteln
|
WO2006123255A2
(en)
|
2005-05-18 |
2006-11-23 |
Addex Pharma Sa |
Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
|
DE102005044813A1
(de)
|
2005-05-19 |
2007-10-04 |
Grünenthal GmbH |
Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
|
DE102005044814A1
(de)
|
2005-05-19 |
2006-11-23 |
Grünenthal GmbH |
Substituierte Sprio-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
|
DE102005023784A1
(de)
|
2005-05-19 |
2006-11-30 |
Grünenthal GmbH |
Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
|
DE102005024012A1
(de)
|
2005-05-20 |
2006-11-23 |
Grünenthal GmbH |
Verwendung von 2,5-disubstituierten Thiazol-4-on-Derivaten in Arzneimitteln
|
US7582611B2
(en)
|
2005-05-24 |
2009-09-01 |
Pfizer Inc. |
Motilide compounds
|
MY147756A
(en)
|
2005-05-25 |
2013-01-15 |
Theravance Inc |
Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
|
EP1902053B1
(en)
|
2005-06-07 |
2011-01-12 |
Theravance, Inc. |
Benzoimidazolone-carboxamide compounds as 5-ht4 receptor agonists
|
US20060293370A1
(en)
|
2005-06-10 |
2006-12-28 |
Saunders Jeffrey O |
Sulfonamide compounds and uses thereof
|
AU2006259891A1
(en)
|
2005-06-23 |
2006-12-28 |
Albireo Ab |
New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
|
EP1899318A4
(en)
|
2005-06-23 |
2010-03-17 |
Astrazeneca Ab |
NEW AZETIDINE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS FOR THE TREATMENT OF STOMACH DARM DISEASES
|
CN101258145A
(zh)
|
2005-07-05 |
2008-09-03 |
阿里克斯治疗公司 |
立体异构吡啶基和吡啶酮基化合物以及治疗胃肠和中枢神经***疾病的方法
|
WO2007004041A2
(en)
|
2005-07-05 |
2007-01-11 |
Orchid Research Laboratories Limited |
New compounds and their pharmaceutical use
|
EP1902022A1
(en)
|
2005-07-12 |
2008-03-26 |
Glaxo Group Limited |
Piperazine heteroaryl derivates as gpr38 agonists
|
WO2007014258A2
(en)
|
2005-07-22 |
2007-02-01 |
Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. |
Growth hormone secretagogues
|
EP1910340B1
(en)
|
2005-07-22 |
2009-11-18 |
Pfizer, Inc. |
Indazolecarboxamide derivatives as 5ht4 receptor agonists
|
MY150098A
(en)
|
2005-07-26 |
2013-11-29 |
Glaxo Group Ltd |
Benzylpiperazine derivates and their medical use
|
EP1757290A1
(en)
|
2005-08-16 |
2007-02-28 |
Zentaris GmbH |
Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
|
EP1940441A4
(en)
|
2005-08-19 |
2010-01-27 |
Ironwood Pharmaceuticals Inc |
COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL DISORDERS
|
WO2007023242A1
(en)
|
2005-08-24 |
2007-03-01 |
Merz Pharma Gmbh & Co. Kgaa |
Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
|
EP1943247A1
(en)
|
2005-08-25 |
2008-07-16 |
Merz Pharma GmbH & Co.KGaA |
Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
|
WO2007030761A2
(en)
|
2005-09-08 |
2007-03-15 |
Smithkline Beecham Corporation |
Acyclic 1,4-diamines and uses thereof
|
JP2009507896A
(ja)
|
2005-09-13 |
2009-02-26 |
パラウ・フアルマ・ソシエダツド・アノニマ |
ヒスタミンh4受容体活性の調節剤としての2−アミノピリミジン誘導体
|
AR057828A1
(es)
|
2005-09-29 |
2007-12-19 |
Astrazeneca Ab |
Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
|
AR056087A1
(es)
|
2005-09-29 |
2007-09-19 |
Astrazeneca Ab |
Derivados de azetidina como antagonistas de receptores de neuroquina nk
|
UY29796A1
(es)
|
2005-09-29 |
2007-04-30 |
Astrazeneca Ab |
Nuevos compuestos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor
|
HUP0500920A2
(en)
|
2005-10-05 |
2007-07-30 |
Richter Gedeon Nyrt |
Oxadiazole derivatives, process for their preparation and their use
|
HUP0500921A2
(en)
|
2005-10-05 |
2007-07-30 |
Richter Gedeon Nyrt |
Tetrazole derivatives, process for their preparation and their use
|
CA2624307C
(en)
|
2005-10-07 |
2014-04-29 |
Glenmark Pharmaceuticals S.A. |
Substituted benzofused derivatives and their use as vanilloid receptor ligands
|
US7902251B2
(en)
|
2005-10-19 |
2011-03-08 |
Allergan, Inc. |
Method for treating pain
|
US20070088073A1
(en)
|
2005-10-19 |
2007-04-19 |
Allergan, Inc. |
Method for treating pain
|
NZ593684A
(en)
|
2005-10-19 |
2012-11-30 |
Gruenenthal Chemie |
Novel vanilloid receptor ligands and their use for producing medicaments
|
US7538110B2
(en)
|
2005-10-27 |
2009-05-26 |
Adolor Corporation |
Opioid antagonists
|
WO2007050732A1
(en)
|
2005-10-28 |
2007-05-03 |
Abbott Laboratories |
INDAZOLE DERIVATIVES THAT INHIBIT TRPVl RECEPTOR
|
WO2007048643A1
(en)
|
2005-10-28 |
2007-05-03 |
Glaxo Group Limited |
Novel compound
|
JP2007122605A
(ja)
|
2005-10-31 |
2007-05-17 |
Fujitsu Ltd |
インピーダンス回路、電源装置
|
US20070105920A1
(en)
|
2005-11-08 |
2007-05-10 |
Akzo Nobel N.V. |
2-(Benzimidazol-1-Yl)-N-(4-phenylthiazol-2-yl) acetamide derivatives
|
GB0525661D0
(en)
|
2005-12-16 |
2006-01-25 |
Glaxo Group Ltd |
Novel compounds
|
NL2000323C2
(nl)
|
2005-12-20 |
2007-11-20 |
Pfizer Ltd |
Pyrimidine-derivaten.
|
WO2007090854A1
(en)
|
2006-02-10 |
2007-08-16 |
Cellzome (Uk) Ltd. |
Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders
|
WO2007090853A1
(en)
|
2006-02-10 |
2007-08-16 |
Cellzome (Uk) Ltd. |
Enantiomers of amino pyrimidine compounds for the treatment of inflammatory disorders
|
EP1829879A1
(en)
|
2006-02-10 |
2007-09-05 |
Cellzome (UK) Ltd. |
Amino pyrimidine compounds for the treatment of inflammatory disorders
|
GB0603550D0
(en)
|
2006-02-22 |
2006-04-05 |
Glaxo Group Ltd |
Novel compounds
|
US20090192083A1
(en)
|
2006-02-24 |
2009-07-30 |
Currie Mark G |
Methods and compositions for the treatment of gastrointestinal disorders
|
EP1996218A4
(en)
|
2006-02-24 |
2012-07-11 |
Ironwood Pharmaceuticals Inc |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
|
US8597562B2
(en)
|
2006-03-30 |
2013-12-03 |
GM Global Technology Operations LLC |
Composite products and methods of making the same
|
TW200808709A
(en)
|
2006-03-31 |
2008-02-16 |
Glaxo Group Ltd |
Novel compounds
|
ES2349237T3
(es)
|
2006-03-31 |
2010-12-29 |
Janssen Pharmaceutica Nv |
Benzoimidazol-2-il pirimidinas como moduladores del receptor de histamina h4.
|
EA016264B1
(ru)
|
2006-03-31 |
2012-03-30 |
Янссен Фармацевтика Н.В. |
Бензоимидазол-2-илпиримидины и пиразины в качестве модуляторов рецептора гистамина н
|
CN101472584B
(zh)
|
2006-04-07 |
2013-04-24 |
詹森药业有限公司 |
用作组胺h4受体调节剂的吲哚类和苯并咪唑类
|
EP2007716A1
(en)
|
2006-04-13 |
2008-12-31 |
Glaxo Group Limited |
Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists
|
MX2009000110A
(es)
|
2006-06-28 |
2009-01-23 |
Glaxo Group Ltd |
Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor grp38.
|
US8088733B2
(en)
|
2006-07-06 |
2012-01-03 |
Tranzyme Pharma Inc. |
Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders
|
WO2008083070A1
(en)
*
|
2006-12-29 |
2008-07-10 |
Neurogen Corporation |
Crf1 receptor ligands comprising fused bicyclic heteroaryl moieties
|
EP2118080B1
(en)
|
2007-02-09 |
2016-08-31 |
Ocera Therapeutics, Inc. |
Macrocyclic ghrelin receptor modulators and methods of using the same
|
TWI423801B
(zh)
|
2007-08-27 |
2014-01-21 |
Theravance Inc |
作為μ類鴉片受體拮抗劑之8-氮雜雙環〔3.2.1〕辛基-2-羥基苯甲醯胺化合物
|
EP2185553B1
(en)
|
2007-08-27 |
2012-06-27 |
Theravance, Inc. |
Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
|
US7947710B2
(en)
|
2007-08-27 |
2011-05-24 |
Theravance, Inc. |
Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
|
ES2465621T3
(es)
|
2007-08-27 |
2014-06-06 |
Theravance, Inc. |
Compuestos de heteroarilalquil-8-azabiciclo[3.2.1]octano, como antagonistas de los receptores opiodes mu
|
DE102008022221A1
(de)
*
|
2008-05-06 |
2009-11-12 |
Universität des Saarlandes |
Inhibitoren der humanen Aldosteronsynthase CYP11B2
|
US8273900B2
(en)
*
|
2008-08-07 |
2012-09-25 |
Novartis Ag |
Organic compounds
|